Angiogenesis in cancer and other diseases - PubMed (original) (raw)
Review
. 2000 Sep 14;407(6801):249-57.
doi: 10.1038/35025220.
Affiliations
- PMID: 11001068
- DOI: 10.1038/35025220
Review
Angiogenesis in cancer and other diseases
P Carmeliet et al. Nature. 2000.
Abstract
Pathological angiogenesis is a hallmark of cancer and various ischaemic and inflammatory diseases. Concentrated efforts in this area of research are leading to the discovery of a growing number of pro- and anti-angiogenic molecules, some of which are already in clinical trials. The complex interactions among these molecules and how they affect vascular structure and function in different environments are now beginning to be elucidated. This integrated understanding is leading to the development of a number of exciting and bold approaches to treat cancer and other diseases. But owing to several unanswered questions, caution is needed.
Similar articles
- [Angiogenesis and tumor growth. Angiogenic factors and tumor growth].
Plouet J. Plouet J. Ann Pathol. 1999;19(5 Suppl):S70-1. Ann Pathol. 1999. PMID: 10599456 French. No abstract available. - Vascular endothelial growth factor as a target for antiangiogenic therapy.
Gordon MS. Gordon MS. J Clin Oncol. 2000 Nov 1;18(21 Suppl):45S-6S. J Clin Oncol. 2000. PMID: 11060326 No abstract available. - Angiogenesis-dependent diseases and angiogenesis therapy.
Tímár J, Döme B, Fazekas K, Janovics A, Paku S. Tímár J, et al. Pathol Oncol Res. 2001;7(2):85-94. doi: 10.1007/BF03032573. Pathol Oncol Res. 2001. PMID: 11458270 Review. - Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
Shinkaruk S, Bayle M, Laïn G, Déléris G. Shinkaruk S, et al. Curr Med Chem Anticancer Agents. 2003 Mar;3(2):95-117. doi: 10.2174/1568011033353452. Curr Med Chem Anticancer Agents. 2003. PMID: 12678905 Review.
Cited by
- Multifunctional vitamin D-incorporated PLGA scaffold with BMP/VEGF-overexpressed tonsil-derived MSC via CRISPR/Cas9 for bone tissue regeneration.
Park SY, Lee JK, Lee SH, Kim DS, Jung JW, Kim JH, Baek SW, You S, Hwang DY, Han DK. Park SY, et al. Mater Today Bio. 2024 Sep 14;28:101254. doi: 10.1016/j.mtbio.2024.101254. eCollection 2024 Oct. Mater Today Bio. 2024. PMID: 39328787 Free PMC article. - Vascularized platforms for investigating cell communication via extracellular vesicles.
Kim J, Ro J, Cho YK. Kim J, et al. Biomicrofluidics. 2024 Sep 23;18(5):051504. doi: 10.1063/5.0220840. eCollection 2024 Sep. Biomicrofluidics. 2024. PMID: 39323481 Review. - CAR T-cells for pediatric solid tumors: where to go from here?
Trautmann T, Yakobian N, Nguyen R. Trautmann T, et al. Cancer Metastasis Rev. 2024 Sep 24. doi: 10.1007/s10555-024-10214-6. Online ahead of print. Cancer Metastasis Rev. 2024. PMID: 39317919 Review. - Opportunities and Challenges of Small Molecule Inhibitors in Glioblastoma Treatment: Lessons Learned from Clinical Trials.
Hoosemans L, Vooijs M, Hoeben A. Hoosemans L, et al. Cancers (Basel). 2024 Aug 29;16(17):3021. doi: 10.3390/cancers16173021. Cancers (Basel). 2024. PMID: 39272879 Free PMC article. Review. - A Deep Learning-Based Framework for Highly Accelerated Prostate MR Dispersion Imaging.
Zhao K, Pang K, Hung AL, Zheng H, Yan R, Sung K. Zhao K, et al. Cancers (Basel). 2024 Aug 27;16(17):2983. doi: 10.3390/cancers16172983. Cancers (Basel). 2024. PMID: 39272841 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources